Colonics
About Me
Recent Posts
- Electromagnetic Biomarker Could Minimize Trial-And-Error Prescribing For Depression
- Endocrine Society Releases Clinical Practice Guideline On Pediatric Obesity
- Key Role In Largest US Children's Study To Be Played By UT Health Science Center At Houston
- Scientists identify a molecule that coordinates the movement of cells
- Maryland Stem Cell Commission Issues Requests For Applications
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Friends
Links
Entry 1 of 389
Last Page | Next Page
4/5/2008
-
First New NNRTI In Nearly A Decade To Benefit Canadians With HIV/AIDS
|
Canadians living with HIV/AIDS now have a new preparation doctoring option, with the recent approval of INTELENCE (etravirine, also known as TMC125) from Tibotec, a division of Janssen-Ortho Inc. INTELENCE is the newest member of the family of AIDS-fighting drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTI), and is the first new NNRTI to be introduced in nearly 10 years. More: - Brought to my attention by |
Post A Comment! :: Send to a Friend! |
Share and enjoy
